XOMA

XOMA

XOMA XOMA NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    XOMA Chart
    See on advanced chart >

    About

    XOMA Corporation, a Delaware corporation, discovers and develops innovative antibody-based therapeutics.The company's lead drug candidate is gevokizumab, a humanized antibody that binds to the inflammatory cytokine interleukin-1 beta. The company has entered...
    • Highlight
      A biotechnology royalty aggregator that develops antibodies and recombinant proteins to treat infectious and immunological diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/06/1986
    • Established Date
      Invalid Date
    • Full-time Employees
      13
    • Address
      2200 Powell Street Suite 310 Emeryville California 94608
    • Tel
      1-510-2047200
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock